Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology.
Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.
Biological psychology represents a fusion of several scientific disciplines - pharmacology, neurobiology, biochemistry, genetics, physiology, anatomy, biophysics and psychology. All are focussed on acquiring an ultimate understanding of the relationships between brain and behaviour. Presented in two volumes are the papers of the 5th World Congress of Biological Psychiatry. Together they represent a significant contribution to complementary advances across a broad front of recently developed research areas. Psychiatric disorders include schizophrenia, affective disorders, the many forms of senile and presenile dementia including Alzheimer's disease, the anxiety disorders, childhood disorders and the variants of eating and sleeping dysfunctions. Each of these illnesses represents a complex interaction of biological, psychological and social variables. The growing number of neuroscientists adopting the biological approach to neuropsychiatric diseases has resulted in a fast expanding body of knowledge regarding brain function and pathology.
Further, psychotherapeutic drugs used to treat psychiatric and neurologic disorders play a crucial role in elucidating the biological bases of these diseases. Studying the mechanism of action of these compounds should give us important clues about the normal and pathological functioning of the brain.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Technology
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
ISBN-13
978-0-444-81410-4 (9780444814104)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
DIAGNOSIS AND CLASSIFICATION. Developing DSM-IV: A preview of the future (3 papers). Classification of depression: from biology to nosology (5 papers). Diagnostic specificity - A useful guide to biological psychiatry? (5 papers). AFFECTIVE DISORDERS: CLINICAL AND BIOLOGICAL RESEARCH. Clinical indices of vulnerability for depression (3 papers). Prophylaxis of affective disorders (4 papers). Biological markers in depression (6 papers). PET and SPECT studies of blood flow/metabolism in affective disorders (2 papers). Biological studies of suicide risk (6 papers). Neurobiology and pharmacotherapy of suicidal behaviour (5 papers). Dysthymia and minor depressive disorder: Diagnosis and treatment possibilities (3 papers). Biological mechanisms in post partum mental illness (4 papers). Depression and stress: Pathophysiological and therapeutic aspects (4 papers). Second messenger transduction in the pathogenesis and treatment of affective disorders (7 papers). The influence of mood stabilizing drugs on cerebral second messenger systems (4 papers). Circadian rhythms in affective disorders: New concepts, novel therapies (2 papers). HPA regulation in depression (5 papers). Pain and depression (9 papers). Optimization of therapeutic outcome with ECT (5 papers). Serotonin uptake inhibitors in depression and other indications (7 papers). Present status on the mode of action of antidepressant drugs (5 papers). New antidepressants: Novel approaches and their implications (5 papers). Onset of action of antidepressant activity: Biological and clinical aspects (6 papers). Lithium potentiation of tricyclic antidepressants: Clinical efficacy and basic machanisms (4 papers). Pharmacokinetics of tricyclic antidepressants and MAO-inhibitors (6 papers). Selective reversible MAO inhibitors as antidepressants (7 papers). Renaissance of MAOIs: The new selective and reversible generation (5 papers). New findings in child psychiatry (4 papers). SCHIZOPHRENIA AND RELATED DISORDERS: CLINICAL AND BIOLOGICAL STUDIES. Epidemiology of schizophrenia (5 papers). Clinical and neurobiological heterogeneity of schizophrenic psychoses (6 papers). Cognitive disturbance and cerebral dysfunction of schizophrenics (4 papers). Cerebral blood flow or metabolic patterns (PET/SPECT) during cognition in schizophrenia (1 paper). Post mortem brain studies in schizophrenia (7 papers). The neuroanatomy of schizophrenia (4 papers). Neurotransmitters in schizophrenia (3 papers). Serotonergic mechanisms in schizophrenia (4 papers). Psychophysiological approaches to schizophrenia (4 papers). Modern trends in the treatment of chronic schizophrenia (4 papers). Mechanism of action of atypical antipsychotic drugs (4 papers). Psychopathological side effects of long-term administration of neuroleptics (6 papers). Tardive dyskinesia: Preclinical and clinical studies (10 papers). STRESS, ANXIETY AND PERSONALITY DISORDERS: PATHOPHYSIOLOGY, BIOLOGY AND TREATMENT ISSUES. Post- traumatic stress disorder (2 papers).
